Abiopharma

A New Press Release from Oncolytics Biotech, Inc

Moderna - Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

New Form 8-K - ARVINAS, INC. Filed: 2025-06-30 AccNo: 0001655759-25-000128 Size: 157 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders

Iterum Names Christine Coyne as Chief Commercial Officer to LeadORLYNVAH™ Launch and Commercial Growth

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

New Form 8-K - Aclaris Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001558370-25-008984 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

Protalix BioTherapeutics Added to Russell3000® and 2000 Indexes®

New Form 8-K - Vicarious Surgical Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059237 Size: 615 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure …

New Form 6-K - GSK plc Filed: 2025-06-30 AccNo: 0001654954-25-007495 Size: 1 MB